LORI FISHBURN: Open Payments
NPI 1922544584 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $188
Food & beverage: $173Education: $15
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $19 |
| Corium, LLC | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Indivior Inc. | 1 | $15 |
Products named: VIVITROL, VRAYLAR, Auvelity, Korlym, Azstarys, Jornay PM, CAPLYTA, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
